Budesonide for Liver Transplant Immune Suppression

Clinical trial NCT03304626 · COMPLETED

Trial details

NCT number: NCT03304626
Sponsor: University of Cincinnati
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Cellular Graft Rejection New Onset Diabetes After Transplant

Start date: 2017-06-27
Primary completion: 2019-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.